FEATURED ARTICLES

• Why Advanced Off-Target Analysis Is Critical For CRISPR's Success

  CRISPR is transforming medicine, but precision remains critical. Off-target effects pose ongoing safety challenges, driving the need for rigorous, multidimensional evaluation strategies.

• CRISPR Reagents Enable High Efficiencies Of Editing And HDR In iPSCs

  Achieving consistent Homology Directed Repair (HDR) in iPSCs requires optimized CRISPR design and workflows. See how advanced reagents and targeted enhancement strategies improve insertion efficiency.

• Advancing The Possibilities Of Protein Engineering Into The Future

  Protein engineering is rapidly shifting toward faster, design-driven innovation. Discover how AI, advanced synthesis, and scalable workflows unlock new applications in drug development.

• The CRISPR Basics Handbook

  Gain a clear understanding of CRISPR fundamentals, from molecular mechanisms to experimental design, as well as how to improve precision and reduce off-target effects for more reliable results.

• Improved Methods For CRISPR-Cas9 Homology-Directed Repair

  Precise genome editing depends on improving HDR efficiency. Learn how guide selection, template design, homology arm optimization, and delivery strategies work together to drive higher-fidelity edits.

• Driving Antibody Discovery With Synthetic Biology

  Synthetic biology is transforming antibody discovery. See how enabling faster screening, greater diversity, and more precise optimization of candidates improves performance and development success.

• DNA Cloning: A Brief Overview Of Cloning And Methods

  Master the essential DNA cloning workflow, compare key assembly methods, and learn how to optimize sequence design to improve efficiency and achieve more reliable cloning outcomes.

• Designing RNase H1 "Gapmer" Antisense Oligonucleotides

  Effective RNA-targeting oligonucleotide design hinges on balancing affinity, stability, and selectivity. Explore how chemical modifications, sequence choices, and delivery approaches influence potency.

• CRISPR Therapeutics: From Editing Basics To Clinical Applications

  Genome editing is redefining disease treatment. Advances in CRISPR tools, delivery, and clinical development are accelerating progress from foundational research to real-world therapeutic applications.

• Maintain Control Of Pharmaceutical Water Systems

  Early TOC excursions often reveal hidden risks in water systems. Capturing samples at the moment of deviation helps teams confirm root causes faster, reduce uncertainty, and maintain control.

• Evaluating Carryover When Using A TOC Analyzer

  Accurate TOC results shouldn’t depend on sample order. See how low-level measurements remain reliable even after high-TOC analysis, helping reduce false positives and streamline decisions.

• AI Agents: The Scientists' New Allies

  AI agents are reshaping biopharma research, offering new ways to analyze data. Find out how success depends on strong data foundations, governance, and thoughtful adoption strategies.

• Advancing An Integrated Biopharma Workflow Strategy

  Global research teams were generating critical data in disconnected systems, hindering collaboration. Explore how unified workflows and a shared data backbone strengthen efficiency.

• How Can Data Translation Challenges In CRO Partnerships Be Overcome?

  Biopharma–CRO partnerships often struggle with fragmented communication. Gain insight into how streamlined, automated workflows improve transparency, data quality, and operational speed.

• Precision Medicine In IMIDs - The Path To Improved Healthcare Outcomes

  Precision medicine is opening new possibilities for IMIDs by moving beyond symptom‑based care. Find out how emerging multi‑omics tools are reshaping how these complex diseases are understood.

• Enhancing Biopharma ROI With In-House Long-Read Sequencing

  Long-read sequencing is redefining research by enabling clearer insights into complex genetic regions. Learn how this technology strengthens data confidence and accelerates modern R&D workflows.

• NGS Revolution For Cell And Gene Therapy Products

  Discover how next-generation sequencing offers a more efficient path to evaluating the critical quality attributes of cell and gene therapies while reducing assay complexity and accelerating progress.

• Enhancing Novel Developability Through Automated MS Analytics

  Growing biotherapeutic complexity demands MS workflows that can unify diverse datasets. Learn how automated approaches enhance data quality, streamline analysis, and support faster development.

• Transforming Development Through Mass Spectrometry Data Analysis

  Mass spectrometry is vital for understanding PTMs in modern biologics. Explore key challenges and how streamlined analysis can reveal deeper, more sensitive insights into biotherapeutic structure.

• End-To-End Workflow Integration For Antibody Development

  Modern antibody discovery generates massive, fragmented datasets that slow collaboration and decision‑making. Examine how unified digital workflows streamline R&D and improve data quality.